- Trials with a EudraCT protocol (1,162)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
1,162 result(s) found for: Chronic Pain.
Displaying page 4 of 59.
EudraCT Number: 2009-009857-17 | Sponsor Protocol Number: 42160443PAI2003 | Start Date*: 2009-12-16 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Dose-Loading Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Inadequate... | |||||||||||||
Medical condition: Moderate to severe, chronic, low back pain (LBP) that is not adequately controlled by standard pain therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005722-35 | Sponsor Protocol Number: H--6-2014-070 | Start Date*: 2015-06-23 | ||||||||||||||||
Sponsor Name:Glostrup University Hospital | ||||||||||||||||||
Full Title: Measures of inflammation in low back pain (LBP) and anti-TNFα for the treatment of deemed discogenic LBP - an explorative study | ||||||||||||||||||
Medical condition: Low back pain with and without legg-pain In the late periode 1990ies it became clear that various cytokines and other inflammatory elements played a large role for low back pain. One of the known ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004609-85 | Sponsor Protocol Number: UV2005/01 | Start Date*: 2008-03-18 | ||||||||||||||||
Sponsor Name:OM Pharma SA | ||||||||||||||||||
Full Title: Multicentre, randomised, double-blind, placebo-controlled clinical study to assess the efficacy and safety of UroVaxom in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) | ||||||||||||||||||
Medical condition: Chronic prostatitis and chronic pelvic pain syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) PT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-015397-35 | Sponsor Protocol Number: KF5503/53 | Start Date*: 2010-02-12 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-... | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022955-43 | Sponsor Protocol Number: A0081256 | Start Date*: 2011-05-17 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK | |||||||||||||
Full Title: OPEN LABEL EUROPEAN STUDY TO SUPPORT THE EARLY IDENTIFICATION OF PATIENTS WITH CHRONIC NEUROPATHIC LOW BACK PAIN IN PRIMARY CARE AND TO ASSESS THE EFFECTIVENESS AND TOLERABILITY OF PREGABALIN IN TH... | |||||||||||||
Medical condition: Pregabalin (Lyrica ®) is approved in the European Union for the treatment of peripheral and central neuropathic pain in adults. The medical condition being investigated in this study is chronic neu... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) GR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000557-35 | Sponsor Protocol Number: NW-1029/001/II/2003 | Start Date*: 2005-06-09 |
Sponsor Name:Newron Pharmaceuticals SpA | ||
Full Title: A phase II, multi centre, pilot, randomised, ascending dose, double -blind, placebo controlled, dose titration study to determine the safety, maximum tolerated dose and preliminary evidence of effi... | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012586-55 | Sponsor Protocol Number: Protocol_DNIC_2009 | Start Date*: 2009-08-27 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Influence of S(+)-ketamine on Diffuse Noxious Inhibitory Control (DNIC) and offset analgesia (OA) in chronic pain patients (neuropathic pain, complex regional pain syndrome type 1, fibromyalgia) an... | ||
Medical condition: Chronic pain patients: CRPS-1, fibromyalgia and neurptahic pain | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000487-27 | Sponsor Protocol Number: 0663-806 | Start Date*: 2004-08-10 | |||||||||||
Sponsor Name:Merck Sharp & Dohme (Sweden) AB | |||||||||||||
Full Title: A Double-Blind, Parallel-Group, 4-week Trial to Assess the Efficacy and Safety of Etoricoxib 60mg and Diclofenac 150mg in Patients with Chronic Low Back Pain | |||||||||||||
Medical condition: Chronic Low Back Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005187-24 | Sponsor Protocol Number: OROS-ANA-3001 | Start Date*: 2005-08-16 | |||||||||||
Sponsor Name:JANSSEN-CILAG | |||||||||||||
Full Title: Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in su... | |||||||||||||
Medical condition: Treatment of chronic non-malignant pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001260-29 | Sponsor Protocol Number: CCH01 | Start Date*: 2019-09-10 | |||||||||||
Sponsor Name:CCH Pharmaceuticals | |||||||||||||
Full Title: Proof of concept study for evaluation of the effect of ketamine intranasal spray in treatment of chronic Cluster Headache (CCH) | |||||||||||||
Medical condition: Chronic Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000095-10 | Sponsor Protocol Number: BATCP | Start Date*: 2015-03-30 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Botulinum toxin-A as a treatment for chronic muscle-related pain in adults with spastic cerebral palsy: a randomized controlled trial. | ||
Medical condition: Spastic cerebral palsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-024320-23 | Sponsor Protocol Number: I4F-EW-CCAC | Start Date*: 2011-03-08 | |||||||||||
Sponsor Name:Chorus, Eli Lilly and Company | |||||||||||||
Full Title: A Proof-of-Concept Study of the Effects of LY2828360 in the Treatment of Patients with Osteoarthritic Knee Pain | |||||||||||||
Medical condition: Pain in osteoarthritic knee. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004888-31 | Sponsor Protocol Number: OXN3508 | Start Date*: 2015-01-26 | |||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | |||||||||||||
Full Title: A randomised, double-blind, double-dummy, cross-over multicenter study to demonstrate equivalence in analgesic efficacy and bowel function taking oxycodone equivalents of 120 and 160 mg per day as ... | |||||||||||||
Medical condition: The intended indication is: Chronic severe non malignant pain, chronic severe malignant pain, requiring opioids. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017470-20 | Sponsor Protocol Number: GRT-CG5503-2009-02-FR | Start Date*: 2010-05-07 | |||||||||||
Sponsor Name:Laboratoires Grünenthal | |||||||||||||
Full Title: An open-label extension study for patients with severe chronic low back pain or severe chronic pain due to knee osteoarthritis who have completed any of the previous phase IIIb trials with tapentad... | |||||||||||||
Medical condition: Severe chronic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010428-25 | Sponsor Protocol Number: KF5503/45 | Start Date*: 2010-02-15 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic nocicept... | |||||||||||||
Medical condition: Low back Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) NL (Completed) DE (Completed) FR (Completed) BE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005035-13 | Sponsor Protocol Number: GaPP2 | Start Date*: 2015-02-13 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: GaPP 2: A multi-centre randomised controlled trial of the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women | |||||||||||||
Medical condition: Chronic pelvic pain of unknown cause | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006390-24 | Sponsor Protocol Number: DISCI-Studie | Start Date*: 2007-03-23 |
Sponsor Name:WALA Heilmittel GmbH | ||
Full Title: Prospektive, randomized, controlled, multicentre, partly double blind study to compare Disci/Rhus toxicodendron comp., placebo and waiting list in patients with chronic low back pain. | ||
Medical condition: chronic low back pain (chronic local or pseudoradiculaere low back pain due to e.g. degenerative basic illness). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001586-32 | Sponsor Protocol Number: GN12RE072 | Start Date*: 2012-12-13 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde | |||||||||||||
Full Title: The role of Qutenza (topical capsaicin 8%) in the treatment of chronic pain from critical ischaemia in patients with end stage renal failure | |||||||||||||
Medical condition: Chronic pain from critical limb ischaemia in patients with end-stage renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000815-42 | Sponsor Protocol Number: HighNxGHR_PK | Start Date*: 2015-04-28 | |||||||||||
Sponsor Name:Rigshospitalet, Copenhagen University Hospitals | |||||||||||||
Full Title: Pharmacokinetics of High-dose Target-controlled Naloxone Infusion. Companion study to: Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia in Patients following Groin-H... | |||||||||||||
Medical condition: Healthy subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005701-20 | Sponsor Protocol Number: ANST2015_1 | Start Date*: 2015-05-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Shifting pain modulation towards anti-nociceptivity: Mechanism-specific pharmacological prevention of post sternotomy pain: the MASTER study | ||
Medical condition: chronic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
